ISRCTN34879893
Completed
Not Applicable
Impact of pharmacist interventions on adherence and measurable patient outcomes among depressed patients: a randomised controlled study
Al Amal Psychiatric Hospital0 sites195 target enrollmentDecember 30, 2014
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Al Amal Psychiatric Hospital
- Enrollment
- 195
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients within the age range of 18 to 60 years
- •2\. Patients newly diagnosed with a MDD, according to the scales in the ?Diagnostic and Statistical Manual of Mental Disorders, 4th Ed (DSM\-IV)
- •3\. Patients having no psychotic or bipolar history
- •4\. Patients having no drug or dependency history
- •5\. Patients having no cognitive impairment that may hinder the assessment?
Exclusion Criteria
- •1\. Patients having a psychiatric or bipolar disorder history
- •2\. Patients having drug or dependency history.
- •3\. Patients suffering from any cognitive impairment that may hinder the ?assessment
- •4\. Patients not responding at any level to the antidepressant within 8 weeks of ?recruitment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPDAsthma COPDNCT06417931University of Ibadan130
Completed
Not Applicable
Evaluation of the effect of medication adherence using Pletaal Assist SystemIschemic strokeJPRN-UMIN000031148Iwate medical university30
Completed
Not Applicable
Pharmacist-led Intervention in Treatment Non-adherence in Southwestern NigeriaDiabetes Mellitus, Type 2NCT04712916University of Ibadan401
Completed
Not Applicable
Effect of interventions to improve the use of inhalers as instructed by the health care providerAsthma and chronic obstructive pulmonary disease (COPD)RespiratoryISRCTN13994441Jawaharlal Institute of Post Graduate Medical Education and Research421
Completed
Phase 2
Primary prevention of cardiovascular disease through community pharmacist management of multiple risk factorsCardiovascular disease riskCardiovascular - Normal development and function of the cardiovascular systemACTRN12609000677202Monash University100